Background. Minimally invasive lung lobectomy and segmentectomy by video-assisted thoracic surgery (VATS) are assumed to result in better quality of life and less postoperative pain compared with standard open approaches. To date, few prospective studies have compared the two approaches. We performed a prospective cohort study to compare quality of life and pain scores during the first 12 months after VATS or open anatomic resection.
Methods. Patients were prospectively enrolled from May 2009 to April 2012. Patients with clinical stage I lung cancer who were scheduled to undergo anatomic lung resection were eligible. The Brief Pain Index and Medical Outcomes Study 36-Item Short Form Health Survey were conducted perioperatively and at four assessments during the first 12 months after the operation. Intent-to-treat analyses using mixed-effects models were used to longitudinally assess the effect of treatment on quality of life components (physical component summary and mental component summary) and pain.
Results. In total, 74 patients underwent thoracotomy, and 132 underwent VATS (including 19 patients who were converted to thoracotomy); 40 and 80 patients, respectively, completed the 12-month surveys. Baseline characteristics were similar between the two groups. Physical component summary and Brief Pain Index scores were similar between the two groups throughout the 12 months of followup. The mental component summary score, however, was consistently worse in the VATS group.
Conclusions. Patient-reported physical component summary and pain scores after VATS and thoracotomy were similar during the first 12 months after surgical resection.
(Ann Thorac Surg 2014;98:1160-6) Ó 2014 by The Society of Thoracic Surgeons V ideo-assisted thoracic surgery (VATS) for anatomic resection of lung cancer has gained wide acceptance in the thoracic surgery community. After some initial concerns regarding the oncologic soundness of the approach compared with open thoracotomy-concerns that have since been mostly dispelled [1] [2] [3] [4] -the technique has been enthusiastically adopted, owing to the perceived advantages of minimally invasive approaches. Indeed, studies (primarily retrospective ones) suggest that the VATS approach has certain physiologic advantages, including less postoperative pain [5, 6] , shorter hospitalization [7] , better tolerability in older patients [8, 9] , and even lower costs [10, 11] .
A significant limitation of most of these studies, however, is their retrospective design, which can introduce significant recollection bias [12] . Furthermore, many of these studies are not analyzed as intent-to-treat, and conversions from VATS to thoracotomy are often inappropriately included in the thoracotomy arm.
Last, and perhaps most important, the focus of many studies assessing the benefits of VATS has been "objective" measures of quality of life (QOL) after the operation, with the implication that these serve as a more accurate reflection of the effect of the operation on patients [13] . However, with the mandate for patient-reported measures as a component of quality care and with future reimbursement of care linked to quality, patient-reported measures of pain and QOL, once marginalized, have gained significantly in importance. We performed a prospective cohort study to compare QOL and pain scores during the first 12 months after VATS or open anatomic resection for early-stage nonsmall cell lung cancer (NSCLC).
Material and Methods
The Memorial Sloan Kettering Cancer Center Institutional Review Board approved this study. All patients gave consent for participation in the study.
Eligibility
Patients were eligible for this study if they had histologically confirmed or suspected clinical stage I [14] NSCLC (as determined by positron emission tomography, computed tomography, and nonroutine invasive mediastinal or hilar staging, or both) and were deemed medically fit for anatomic lung resection (segmentectomy or lobectomy). Patients were excluded if they had undergone a previous lung resection or had received preoperative chemotherapy or radiotherapy, or both. Patients who had disease of a more advanced stage or who did not have NSCLC after the operation were removed from the study.
Patients were invited to participate in the study after consenting to their surgical procedure. The choice of surgical approach (thoracotomy vs VATS and lobectomy vs segmentectomy) was determined by surgeon preference (thoracotomy is the standard preference for 3 surgeons in the group; VATS, for 5).
Thoracotomy was defined as a procedure that included any rib spreading, including standard posterolateral thoracotomy and muscle-sparing axillary thoracotomy. VATS was performed through 3 incisions, with the largest (utility) incision approximately 4 cm in size. Some VATS cases included robotic assistance with the da Vinci Surgical System (Intuitive Surgical, Sunnyvale, CA).
Operations were considered conversions if the initial attempt at resection was performed using VATS but was aborted due to technical difficulties such as bleeding or adhesions. If the VATS procedure was primarily used for staging, with no true intent to resect, the operation was considered a thoracotomy. Because more surgeons in our group typically perform VATS resections in this cohort of patients, rather than thoracotomies, our accrual target was 80 VATS patients and 40 thoracotomy patients who completed the 12-month follow-up evaluations.
Demographic Data Collected
We prospectively collected data from all patients, including demographic characteristics, comorbidities, lung function test results, pathologic stage, tumor type, any postoperative morbidity, hospital length of stay, and disease status during the 12 months of follow-up.
QOL Measures
We obtained data on health-related QOL using the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36). The SF-36 taps 8 health domains: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Each of the 8 domains is scored on a Likert-like scale (1 to 5), with higher scores indicating better QOL. Factor analyses of the SF-36 provide strong support for a two-factor model of health, with one factor encompassing aspects of physical health and the second encompassing aspects of emotional health. Physical component summary (PCS) and mental component summary (MCS) scales from the SF-36 have been standardized to national norms [15] . Reliability estimates for the PCS and MCS exceeded 0.90 [16] , and internal consistency reliability estimates for all scales were 0.78 or higher.
After registration and enrollment, patients completed the SF-36 survey preoperatively, at the first postoperative visit (w2 weeks after discharge), and at the 4-month, 8-month, and 12-month postoperative visits. If a documented recurrence developed during follow-up, no additional QOL surveys were collected from the patient.
Pain Measures
Pain was measured using the Brief Pain Inventory (BPI). The BPI is a pain assessment tool used to measure pain intensity and pain interference in cancer patients [17, 18] . Patients rate the severity of their pain at its worst and least during the previous week, on average, and "right now" [18] . Patients rate their level of pain interference in 7 contexts: (1) work, (2) activity, (3) mood, (4) enjoyment, (5) sleep, (6) walking, and (7) relationships [19] . The BPI also assesses the patient's pain intervention, pain quality, and perception of the cause of pain. Other BPI items include (1) a shade-in of the patient's area of pain on a front and back view of a human figure; (2) rating the amount of relief the patient feels that the current pain treatments provide; (3) rating the duration of the patient's pain relief after taking prescribed pain medications; and (4) assessing the patient's attribution of pain to the disease, the treatment of the disease, or conditions unrelated to the disease. The scale does not have a scoring algorithm, but "worst pain" or the arithmetic mean of the 4 severity items can be used as measures of pain severity, and the arithmetic mean of the 7 interference items can be used as a measure of pain interference [18] .
After registration and enrollment, patients completed the BPI preoperatively, on postoperative days 2 to 4 (while still hospitalized), at the initial postoperative visit (w2 weeks after discharge), and at the 4-month, 8-month, and 12-month postoperative visits. If a documented recurrence developed during follow-up, no additional BPI surveys were collected from the patient.
Pain Management
All patients received an epidural catheter before their operation. Most commonly, the epidural infusion was begun in the operating room, using bupivacaine only, followed postoperatively by an infusion of hydromorphone (8 mg/mL) and bupivacaine (0.05%) at 6 mL/h, with a 6-mL bolus. Toradol (Roche, Basel Switzerland) was also used when not contraindicated by renal function. The Anesthesia Pain Service, which is present in the hospital 24 hours a day, managed the epidural catheters.
After the epidural catheter was removed, oral narcotics were prescribed as needed.
Statistical Methods
We compared demographic characteristics between the VATS and thoracotomy cohorts using c
QOL analysis investigated two end points: PCS and MCS, each of which was analyzed in a longitudinal fashion using linear mixed-effects models that included all patients who had the baseline assessment and at least one post-baseline (outpatient) assessment. All models included a time effect and were adjusted for baseline QOL as well as for demographic and disease characteristics that were differently distributed in the two cohorts. In addition, an interaction between treatment group and time was included to allow for the possibility that changes in QOL over time were different between the VATS group and the thoracotomy group. We used these models to calculate adjusted PCS and MCS scores at each time point and compared them using contrasts.
Pain analysis investigated two end points: average pain, defined as the mean across the 4 reported pain scores (worst, least, average, and right now), and average interference, defined as the mean across the 7 scores examining interference (general activity, mood, walking ability, normal work, relations, sleep, and life enjoyment). For each end point, the inpatient pain scores were log-transformed and modeled using linear mixed-effects models. Outpatient pain scores were categorized as clinically significant (score 4) [20, 21] or not (score <4) and analyzed using nonlinear mixed-effect models, with the same approach as described above for QOL analyses.
To account for the possibility that missing reports of QOL or pain were related to the actual outcomes (informative missingness), we used a pattern-mixture models approach and stratified all models by the observed pattern of missing data [22] .
Statistical analysis was conducted using SAS 9.2 software (SAS Institute, Cary, NC). All significance tests were 2-sided and used a 5% level of significance.
Results
Patients were prospectively enrolled from May 2009 to April 2012. In total, 74 patients underwent thoracotomy (72 of whom completed the baseline surveys), and 132 underwent VATS (19 patients were converted from VATS to thoracotomy and were analyzed in the VATS arm); 40 and 80 patients, respectively, were followed up for 12 months and completed the final survey, representing 59% of all patients who consented to participate in the study (55% thoracotomy patients vs 61% VATS patients; p ¼ 0.58). The study was closed when the target sample size, based on a 12-month follow-up, was reached. Fewer than 12 months of data were collected for 45 patients (22%) because of study completion. In the remaining patients, incomplete data were attributable to dropout in 19 (9%) or death or disease recurrence in 18 (9%); in addition, 4 patients received postoperative chemotherapy and were therefore removed from the study (Table 1) .
Baseline characteristics were similar between the VATS and thoracotomy groups. There was one 30-day death in the VATS arm and none in the thoracotomy arm. Length of stay was similar between the groups. Postoperative complications are listed in Table 2 .
Adjusted PCS scores were similar between the groups throughout the course of follow-up, whereas adjusted MCS scores were consistently better in the thoracotomy group (Fig 1 and Table 3 ). For each pain outcome investigated, adjusted pain scores were likewise similar between groups during the postoperative period (days 2 to 4; Fig 2) . No difference was found between groups with respect to the risk of having clinically significant pain at each of the outpatient postoperative evaluations (months 4, 8, and 12; Fig 3, Table 4 ).
Comment
The results from this prospective study indicate that there is no quantifiable difference in pain and QOL between VATS and thoracotomy for the treatment of stage I NSCLC, with the exception of the SF-36 MHS scores, which were consistently higher (ie, better) in the thoracotomy group. QOL scores in both groups improved throughout the 12 months of follow-up, and pain scores approached baseline levels by 4 months. A similar number of patients in both groups reported no longer using narcotics at the first postoperative visit (13% for VATS vs 6% for thoracotomy; data not shown), and, likewise, by 12 months, the incidence of reported residual pain at the surgical site was similar (28% for VATS vs 37% for thoracotomy).
A possible explanation for the similarity in pain scores between the groups is that the pain control provided by the epidural catheter, with the addition of Toradol and the presence of a full-time pain service, was sufficient to mask any potential differences between the surgical approaches. Although we did not capture any data between the time of discharge and the first follow-up visit-and, therefore, may have missed differences in pain scores during this period-it is more likely that the two groups achieved similar pain control with narcotics, given the similar narcotic usage between the two groups. A second possible explanation (not supported by our data) is that, owing to the intent-to-treat analysis, patients who were converted to open approaches (14%) had a significant effect on the perceived benefits of VATS; however, when we looked at this group separately, the differences between the groups were not significant (data not shown).
Last, why the MCS scores were consistently worse in the VATS arm is unclear. Accounting for the subjectivity of the surveys is difficult, and it is perhaps the case that patient expectations played a large role in the responses to this question; that is, their responses might have indicated that they experienced more or less pain than they had expected. On one hand, although the differences in the MCS scores were statistically significant, this difference is typically not considered clinically meaningful [18] . On the other hand, PCS scores were consistently similar during the study period.
The study has several possible limitations. The most obvious is that the patients could not be randomized between the two surgical arms. Given the lack of equipoise among surgeons, a randomized trial is not feasible in this setting. Because the patients at our institution are essentially randomized to the surgeon they see, and because the surgical approach performed reflects the standard practice of each surgeon and is generally not influenced by the patient's prognosis, this potential source of selection bias should have been significantly mitigated. Moreover, one could argue that randomizing patients to surgical procedures against their own preferences or biases could influence their responses to subjective surveys.
A second possible limitation is that only 59% of patients completed all surveys. In fact, this is a common problem in QOL studies and can introduce significant bias, depending on the reason why patients did not complete all surveys. The analysis method that we used (mixture patterns for longitudinal data) is designed to account for this potentially informative dropout. However, if some of the patients dropped out for reasons related to their pain or QOL, it is possible that this may have influenced the results.
The most common reason for incomplete follow-up in this study was administrative and unrelated to patients' outcomes: the study was stopped when the planned number of patients completed 12 months of follow-up (22% of consented patients had incomplete data for this reason). In addition, our pattern-mixture models analysis accounts for potential informative missingness associated with 9.3% of the consented patients who dropped out during the follow-up period for unexplained reasons [23] . Last, we analyzed the data according to an intent-totreat analysis, therefore including in the VATS group the 19 patients who were intraoperatively converted to thoracotomy. Although it could be argued that their subsequent QOL and pain outcomes were attributable to the more extensive procedure, we strongly believe that the true representation of an operation must include all possible outcomes, including unforeseen complications, which may lead to a change of operation.
In accordance with the underlying belief that VATS is better tolerated by patients, our expectation in designing this trial was that the VATS group would be associated with better QOL and pain scores. This belief is supported by retrospective studies, including one from our institution [9] , which suggest that VATS procedures are better tolerated than thoracotomies. Yet, although this belief in VATS may seem intuitive, when these assumptions are tested prospectively, they are frequently shown to be erroneous-as was demonstrated definitively in comparisons between laparoscopic and open colectomies [24] . Ultimately, these QOL and pain surveys reflect patient-reported outcomes, and despite our own prejudices, the choice of operative approach needs to reflect that reality. 
